Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.

Stewart AK, Bergsagel PL, Greipp PR, Dispenzieri A, Gertz MA, Hayman SR, Kumar S, Lacy MQ, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Reeder CB, Roy V, Kyle RA, Rajkumar SV, Fonseca R.

Leukemia. 2007 Mar;21(3):529-34. Epub 2007 Jan 18.

PMID:
17230230
2.

Prognostic and therapeutic significance of myeloma genetics and gene expression profiling.

Stewart AK, Fonseca R.

J Clin Oncol. 2005 Sep 10;23(26):6339-44. Review.

PMID:
16155017
3.

Myeloma: classification and risk assessment.

Fonseca R, Monge J.

Semin Oncol. 2013 Oct;40(5):554-66. doi: 10.1053/j.seminoncol.2013.07.002. Review.

PMID:
24135400
4.

Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approach.

Fonseca R, Stewart AK.

Mol Cancer Ther. 2007 Mar;6(3):802-10. Review.

5.

Review of molecular diagnostics in multiple myeloma.

Stewart AK, Fonseca R.

Expert Rev Mol Diagn. 2007 Jul;7(4):453-9. Review.

PMID:
17620051
6.

Risk stratification in the era of novel therapies.

San-Miguel J, Mateos MV, Gutierrez NC.

Cancer J. 2009 Nov-Dec;15(6):457-64. doi: 10.1097/PPO.0b013e3181c51efa. Review.

PMID:
20010164
7.

Prognostic impact of cytogenetic aberrations in patients with multiple myeloma or monoclonal gammopathy of unknown significance.

Schilling G, Dierlamm J, Hossfeld DK.

Hematol Oncol. 2005 Sep-Dec;23(3-4):102-7. Review.

PMID:
16342296
8.

Clinical implications of chromosomal abnormalities in multiple myeloma.

Terpos E, Eleutherakis-Papaiakovou V, Dimopoulos MA.

Leuk Lymphoma. 2006 May;47(5):803-14. Review.

PMID:
16753864
9.

Treatment of myeloma.

Smith ML, Newland AC.

QJM. 1999 Jan;92(1):11-4. Review.

PMID:
10209667
10.

Chromosome 13 deletion/hypodiploidy and prognosis in multiple myeloma patients.

Fassas AB, Tricot G.

Leuk Lymphoma. 2004 Jun;45(6):1083-91. Review.

PMID:
15359986
11.

Multiple myeloma: Implementing signaling pathways and molecular biology in clinical trials.

Bazzi M, Badros A.

Cancer Biol Ther. 2010 Nov 1;10(9):830-8. Epub 2010 Nov 1. Review.

PMID:
21045554
12.

Identification and validation of novel therapeutic targets for multiple myeloma.

Hideshima T, Chauhan D, Richardson P, Anderson KC.

J Clin Oncol. 2005 Sep 10;23(26):6345-50. Review.

PMID:
16155018
13.

[Molecular genetic methods for the prognostic criteria in multiple myeloma].

Mikala G, Jákó J, Vályi-Nagy I.

Orv Hetil. 2005 Aug 7;146(32):1673-82. Review. Hungarian.

PMID:
16149245
14.

Fundamentals in the management of multiple myeloma.

Fadilah SA.

Med J Malaysia. 2010 Sep;65(3):231-9. Review.

15.

The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.

Sawyer JR.

Cancer Genet. 2011 Jan;204(1):3-12. doi: 10.1016/j.cancergencyto.2010.11.002. Review.

PMID:
21356186
16.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
17.

Optimising patient outcomes in myeloma.

Harousseau JL.

Cancer Treat Rev. 2010 May;36 Suppl 2:S33-5. doi: 10.1016/S0305-7372(10)70010-4. Review.

PMID:
20472187
18.

The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.

Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio M, Cox MC, Cuneo A, Del Poeta G, Dini D, Falzetti D, Fanin R, Gobbi M, Isidori A, Leoni F, Liso V, Malagola M, Martinelli G, Mecucci C, Piccaluga PP, Petti MC, Rondelli R, Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli F, Tura S.

Leukemia. 2001 Jun;15(6):903-9. Review.

PMID:
11417475
19.

Presentation and risk stratification--improving prognosis for patients with multiple myeloma.

Lonial S.

Cancer Treat Rev. 2010 May;36 Suppl 2:S12-7. doi: 10.1016/S0305-7372(10)70007-4. Review.

PMID:
20472183
20.

Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.

Rajkumar SV, Buadi F.

Best Pract Res Clin Haematol. 2007 Dec;20(4):665-80. Review.

PMID:
18070712

Supplemental Content

Support Center